{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T01:11:55Z","timestamp":1773796315258,"version":"3.50.1"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,14]],"date-time":"2023-12-14T00:00:00Z","timestamp":1702512000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neoplasia"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.neo.2023.100957","type":"journal-article","created":{"date-parts":[[2023,12,21]],"date-time":"2023-12-21T17:10:01Z","timestamp":1703178601000},"page":"100957","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Immune infiltration, aggressive pathology, and poor survival outcomes in RECQL helicase deficient breast cancers"],"prefix":"10.1016","volume":"47","author":[{"given":"Ayat","family":"Lashen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdulbaqi","family":"Al-Kawaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6133-224X","authenticated-orcid":false,"given":"Jennie N","family":"Jeyapalan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shatha","family":"Alqahtani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed","family":"Shoqafi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mashael","family":"Algethami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Toss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew R","family":"Green","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5438-1126","authenticated-orcid":false,"given":"Nigel P","family":"Mongan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sudha","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad R","family":"Akbari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5009-5525","authenticated-orcid":false,"given":"Emad A","family":"Rakha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5354-5480","authenticated-orcid":false,"given":"Srinivasan","family":"Madhusudan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neo.2023.100957_bib0001","doi-asserted-by":"crossref","DOI":"10.1016\/j.dnarep.2020.102994","article-title":"DNA helicases and their roles in cancer","volume":"96","author":"Dhar","year":"2020","journal-title":"DNA Repair"},{"key":"10.1016\/j.neo.2023.100957_bib0002","doi-asserted-by":"crossref","DOI":"10.3390\/genes11060622","article-title":"RECQ1 helicase in genomic stability and cancer","volume":"11","author":"Debnath","year":"2020","journal-title":"Genes"},{"key":"10.1016\/j.neo.2023.100957_bib0003","doi-asserted-by":"crossref","first-page":"989","DOI":"10.4161\/cc.7.8.5707","article-title":"Unique and important consequences of RECQ1 deficiency in mammalian cells","volume":"7","author":"Sharma","year":"2008","journal-title":"Cell Cycle"},{"key":"10.1016\/j.neo.2023.100957_bib0004","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.dnarep.2012.04.003","article-title":"RECQ1 plays a distinct role in cellular response to oxidative DNA damage","volume":"11","author":"Sharma","year":"2012","journal-title":"DNA Repair"},{"key":"10.1016\/j.neo.2023.100957_bib0005","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/ng.3284","article-title":"Germline RECQL mutations are associated with breast cancer susceptibility","volume":"47","author":"Cybulski","year":"2015","journal-title":"Nat. Genet."},{"key":"10.1016\/j.neo.2023.100957_bib0006","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1158\/1535-7163.MCT-16-0290","article-title":"Clinicopathological and functional significance of RECQL1 helicase in sporadic breast cancers","volume":"16","author":"Arora","year":"2017","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.neo.2023.100957_bib0007","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.877617","article-title":"High expression of RECQL protein in ER-positive breast tumours is associated with a better survival","volume":"12","author":"Mahmoodi","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.neo.2023.100957_bib0008","doi-asserted-by":"crossref","DOI":"10.1128\/MCB.00515-20","article-title":"Genome-wide analysis unveils DNA helicase RECQ1 as a regulator of estrogen response pathway in breast cancer cells","volume":"41","author":"Lu","year":"2021","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.neo.2023.100957_bib0009","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.ccell.2020.10.001","article-title":"The challenges of tumor mutational burden as an immunotherapy biomarker","volume":"39","author":"Jardim","year":"2021","journal-title":"Cancer Cell"},{"key":"10.1016\/j.neo.2023.100957_bib0010","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1158\/2326-6066.CIR-16-0195","article-title":"Clinical impact of tumor DNA repair expression and T-cell infiltration in breast cancers","volume":"5","author":"Green","year":"2017","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.neo.2023.100957_bib0011","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/ni1572","article-title":"The Foxp3+ regulatory T cell: a jack of all trades, master of regulation","volume":"9","author":"Tang","year":"2008","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.neo.2023.100957_bib0012","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/j.immuni.2019.03.021","article-title":"The IL-17 family of cytokines in health and disease","volume":"50","author":"McGeachy","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.neo.2023.100957_bib0013","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.cyto.2013.07.022","article-title":"IL-17 family: cytokines, receptors and signaling","volume":"64","author":"Gu","year":"2013","journal-title":"Cytokine"},{"key":"10.1016\/j.neo.2023.100957_bib0014","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.107544","article-title":"The potential role and status of IL-17 family cytokines in breast cancer","volume":"95","author":"Song","year":"2021","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.neo.2023.100957_bib0015","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/nri.2017.108","article-title":"The diverse functions of the PD1 inhibitory pathway","volume":"18","author":"Sharpe","year":"2018","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.neo.2023.100957_bib0016","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.semcancer.2019.12.003","article-title":"PD-L1 status in breast cancer: current view and perspectives","volume":"72","author":"Vranic","year":"2021","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.neo.2023.100957_bib0017","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1038\/ng.2764","article-title":"The cancer genome atlas pan-cancer analysis project","volume":"45","author":"Cancer Genome Atlas Research","year":"2013","journal-title":"Nat. Genet."},{"key":"10.1016\/j.neo.2023.100957_bib0018","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0092-8674(02)00868-1","article-title":"LINE drive. retrotransposition and genome instability","volume":"110","author":"Kazazian","year":"2002","journal-title":"Cell"},{"key":"10.1016\/j.neo.2023.100957_bib0019","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1038\/nrg2640","article-title":"The impact of retrotransposons on human genome evolution","volume":"10","author":"Cordaux","year":"2009","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.neo.2023.100957_bib0020","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/nrc.2015.21","article-title":"BRCAness revisited","volume":"16","author":"Lord","year":"2016","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.neo.2023.100957_bib0021","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1158\/0008-5472.CAN-16-0794","article-title":"Human cancers express a mutator phenotype: hypothesis, origin, and consequences","volume":"76","author":"Loeb","year":"2016","journal-title":"Cancer Res."},{"key":"10.1016\/j.neo.2023.100957_bib0022","doi-asserted-by":"crossref","first-page":"e797","DOI":"10.1136\/bmj.e797","article-title":"Ductal carcinoma in situ of the breast","volume":"344","author":"Barnes","year":"2012","journal-title":"BMJ"},{"key":"10.1016\/j.neo.2023.100957_bib0023","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1002\/path.1691","article-title":"Molecular evolution of breast cancer","volume":"205","author":"Simpson","year":"2005","journal-title":"J. Pathol."},{"key":"10.1016\/j.neo.2023.100957_bib0024","doi-asserted-by":"crossref","first-page":"6818","DOI":"10.1158\/0008-5472.CAN-18-0633","article-title":"Targeting PARP1 in XRCC1-deficient sporadic invasive breast cancer or preinvasive ductal carcinoma in situ induces synthetic lethality and chemoprevention","volume":"78","author":"Ali","year":"2018","journal-title":"Cancer Res."},{"key":"10.1016\/j.neo.2023.100957_bib0025","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s10549-021-06357-7","article-title":"The frequency and clinical significance of DNA polymerase beta (POLbeta) expression in breast ductal carcinoma in situ (DCIS)","volume":"190","author":"Al-Kawaz","year":"2021","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.neo.2023.100957_bib0026","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1200\/JCO.2010.30.5037","article-title":"Tumor-infiltrating CD8+ lymphocytes predict clinical outcome in breast cancer","volume":"29","author":"Mahmoud","year":"2011","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.neo.2023.100957_bib0027","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1093\/annonc\/mdu191","article-title":"Association between CD8+ T-cell infiltration and breast cancer survival in 12,439 patients","volume":"25","author":"Ali","year":"2014","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.neo.2023.100957_bib0028","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1038\/s41416-021-01514-7","article-title":"Tumour-infiltrating CD4-, CD8- and FOXP3-positive immune cells as predictive markers of mortality in BRCA1- and BRCA2-associated breast cancer","volume":"125","author":"Jorgensen","year":"2021","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.neo.2023.100957_bib0029","doi-asserted-by":"crossref","first-page":"zcad031","DOI":"10.1093\/narcan\/zcad031","article-title":"DNA mismatch repair in cancer immunotherapy","volume":"5","author":"Guan","year":"2023","journal-title":"NAR Cancer"},{"key":"10.1016\/j.neo.2023.100957_bib0030","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11030362","article-title":"Integrated analysis of germline and tumor DNA identifies new candidate genes involved in familial colorectal cancer","volume":"11","author":"Diaz-Gay","year":"2019","journal-title":"Cancers"},{"key":"10.1016\/j.neo.2023.100957_bib0031","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s10549-010-0987-8","article-title":"An evaluation of the clinical significance of FOXP3+ infiltrating cells in human breast cancer","volume":"127","author":"Mahmoud","year":"2011","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.neo.2023.100957_bib0032","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","article-title":"The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data","volume":"2","author":"Cerami","year":"2012","journal-title":"Cancer Discov."},{"key":"10.1016\/j.neo.2023.100957_bib0033","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol."},{"key":"10.1016\/j.neo.2023.100957_bib0034","doi-asserted-by":"crossref","first-page":"W199","DOI":"10.1093\/nar\/gkz401","article-title":"WebGestalt 2019: gene set analysis toolkit with revamped UIs and APIs","volume":"47","author":"Liao","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.neo.2023.100957_bib0035","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s13072-019-0316-3","article-title":"The SMART App: an interactive web application for comprehensive DNA methylation analysis and visualization","volume":"12","author":"Li","year":"2019","journal-title":"Epigenet. Chromatin"},{"key":"10.1016\/j.neo.2023.100957_bib0036","doi-asserted-by":"crossref","first-page":"15330","DOI":"10.1074\/jbc.RA119.008420","article-title":"The DNA repair helicase RECQ1 has a checkpoint-dependent role in mediating DNA damage responses induced by gemcitabine","volume":"294","author":"Parvathaneni","year":"2019","journal-title":"J. Biol. Chem."}],"container-title":["Neoplasia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476558623000805?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476558623000805?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T13:13:15Z","timestamp":1761484395000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1476558623000805"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":36,"alternative-id":["S1476558623000805"],"URL":"https:\/\/doi.org\/10.1016\/j.neo.2023.100957","relation":{},"ISSN":["1476-5586"],"issn-type":[{"value":"1476-5586","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immune infiltration, aggressive pathology, and poor survival outcomes in RECQL helicase deficient breast cancers","name":"articletitle","label":"Article Title"},{"value":"Neoplasia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neo.2023.100957","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100957"}}